AI assistant
Sanofi India Ltd — Board/Management Information 2022
Apr 18, 2022
59270_rns_2022-04-18_ac64fbd6-ae1a-452d-a33b-a428c8a3c470.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [111 x 29] intentionally omitted <==
18[th] April 2022
The Secretary The Secretary, Bombay Stock Exchange Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor Dalal Street Plot No. C/1, G Block Mumbai 400 001 Bandra-Kurla Complex Bandra East Mumbai 400 050
Sub: Appointment of Managing Director
Dear Sirs,
The Board of Directors of the Company at its Meeting held today, based on recommendation of the Nomination and Remuneration Committee approved the appointment of Mr. Rodolfo Hrosz as the Additional Director of the Company with effect from 1[st] June 2022 and as the Managing Director for a period of three years with effect from 1[st] June 2022, subject to approval of the shareholders and other regulatory approvals, as may be required.
Mr. Rodolfo Hrosz is not related to any Director of the Company and is not debarred from holding the office of Director by virtue of any SEBI order or any other Authority.
The Press Release in this regard, is enclosed.
Please take the above information on record.
Thanking you,
Yours faithfully For Sanofi India Limited
==> picture [160 x 45] intentionally omitted <==
Radhika Shah Company Secretary & Compliance Officer
Membership No: A19308
Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number : L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: [email protected]
Press Release
==> picture [109 x 30] intentionally omitted <==
Sanofi India appoints new Managing Director
MUMBAI – April 18, 2022 - Sanofi India Limited (SIL) announced today that its Board of Directors has appointed Rodolfo Hrosz as the Company’s new Managing Director with effect from 1[st] June 2022, subject to regulatory approvals. He will transition from being Sanofi’s General Manager, Consumer Healthcare business in Brazil to his new role in India as soon as the applicable regulatory approvals are in place.
Rodolpho joined Sanofi as General Manager of the Consumer Healthcare business in Brazil in 2017 and has successfully led the organization through several transformative stages, right from the business unit’s inception to it becoming a top growth contributor and a digital-acceleration reference point within the Sanofi Group.
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies. Prior to joining Sanofi, he has worked with Pfizer, LVMH, Heineken and Procter & Gamble in USA and in Brazil.
==> picture [139 x 139] intentionally omitted <==
Increasingly, companies are appreciating the value brought through diversity and inclusion. With Rodolfo at the helm as Sanofi India’s new Managing Director, the Company is geared to mobilize energies, increase agility, and face the new challenges of our industry. His diverse global experiences, particularly in key emerging markets, are assets that will hugely benefit the Company’s development.
Aditya Narayan
Chairman of the Board, Sanofi India Limited
“We are delighted to have Rodolfo Hrosz join Sanofi India as its Managing Director and look forward to his leading the team in the further development of the Company. His wide experience and diverse skills make him eminently suitable for this role and we wish him all the very best for every success in his new assignment.”
About Sanofi in India
As Sanofi India, we are in a great place to make a difference. For six decades, we have earned the trust of our customers and stakeholders for our commitment to promoting health. While pursuing our purpose of chasing miracles of science to benefit people’s lives, we engage across the entire health spectrum from prevention with vaccines to wellness, treatment, patient support & capacity building. Our local entities include Sanofi India Limited (listed in the stock exchange) and Sanofi Healthcare India Pvt. Ltd. (SHIPL).
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Media Relations
==> picture [44 x 13] intentionally omitted <==
Agency Partner Siddhartha Kashyap | [email protected] Nithin Pulikkakunnel | [email protected]
Aparna Thomas | [email protected] Vinifer Gandhi | [email protected]
1/1